Post by
gojotv! on Nov 28, 2022 2:44am
SZLS will soon add Glioblastoma and Pancreatic cancer to...
It's Aristotle diagnostic blood test.
Both those cancers are difficult to diagnose in the early stages, and will elicit real interest in Aristotle.
I wonder if Eric Idle's pancreatic cancer was found by Aristotle-involved researchers...? I mean, he said his cancer was found by a friend at Cambridge working on a new test... and Tripp is a Cambridge alum who's about in Eric Idle's age group...
This is getting very interesting...
GLTA investors!
Comment by
LithLover on Nov 28, 2022 9:09am
Nearing 300 reads in just a few hours. Sure there is not much interest in this stock
Comment by
IainCaimbeul on Nov 28, 2022 9:43am
Another one of gojotv's fairy tales. Going forward Aristotle may well add other diseases to the platform; tieingTripp and Idle together is pure speculation.
Comment by
Liked2Think on Nov 28, 2022 11:36am
so the plan with a product that no one buys is to make a better version of it? I thought Aristotle was a better colonsentry? nothing has sold
Comment by
LithLover on Nov 28, 2022 1:47pm
See I averaged down to 0.0725. Not just a pretty face.
Comment by
Nailbiter2 on Nov 28, 2022 10:00am
This post has been removed in accordance with Community Policy
Comment by
LithLover on Nov 28, 2022 10:08am
Not Stage and here I went and bought a boatload of shares this morning: 09:30:00 D 0.075 0.005 1 80 National Bank 80 National Bank E gojotv! ytou owe me 0.075.
Comment by
Nailbiter2 on Nov 28, 2022 10:15am
This post has been removed in accordance with Community Policy
Comment by
Dowler8765 on Nov 28, 2022 10:41am
This post has been removed in accordance with Community Policy
Comment by
Liked2Think on Nov 28, 2022 12:07pm
you have burst the pumpers pathetic bubble
Comment by
Liked2Think on Nov 28, 2022 12:20pm
I got 6 reads all by myself. Makes ya feel good I guess not surprised gojo the moron does this
Comment by
LithLover on Nov 28, 2022 12:47pm
Where's Jonny with the obvious. I guess you can't trust anything on this board including number of reads.